Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, announced that it submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) in March to seek clearance for sacrocolpopexy, sacrocervicopexy,...
READ MORE




